2 min read
Press Releases


1 min read
AGC Biologics Named Manufacturing Company of the Year by American Business Awards

2 min read
AGC Biologics Honored as a Top 10 Company for Pharma Quality Assurance

1 min read
Tony Fraij Joins Colorado BioScience Association Board of Directors

2 min read
AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus

1 min read
Allergy Therapeutics Selects AGC Biologics to Manufacture Peanut Allergy Vaccine Candidate

1 min read
AGC Biologics Supports BioNTech Omicron-based Vaccine Candidate with pDNA Starting Material

1 min read
AGC Biologics Names Regina Choi-Rivera General Manager of Boulder Facility

1 min read
AGC Biologics Appoints Whitney Sandberg as the new Vice President of Quality for its Colorado Facilities

1 min read
I-MAB Biopharma and AGC Biologics Partner on Late-Phase Project

2 min read
AGC Biologics Receives Transatlantic Award for Investments in Milan Biopharmaceutical Industry

2 min read
4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab

1 min read
AGC Biologics Appoints Jean-Baptiste Agnus as Chief Business Officer


2 min read
AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site
1 min read
AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site
1 min read
AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
1 min read
AGC Biologics Appoints Kevin Ingham as the new General Manager/Site Head of their Seattle, Washington Site
4 min read
Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/III
1 min read
AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine
2 min read
AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics
2 min read
Oculis Selects AGC Biologics’ Heidelberg Facility to Manufacture OCS-02
1 min read
Horizon Therapeutics plc Selects AGC Biologics to Further Supply KRYSTEXXA® (pegloticase injection) at AGC’s Copenhagen Facility
1 min read
AGC Biologics Appoints Jun Takami to General Manager/Site Head of Their Chiba, Japan Site
2 min read
AGC Biologics to Present Their End-to-End Cell and Gene Therapy Offering at ARM’s Meeting on the Mediterranean Conference
1 min read
AGC Biologics Announces the Expansion of Their Cell and Gene Therapy Facility in Milan, Italy
1 min read
AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site
3 min read
AGC Biologics Confirms Cell and Gene Therapy Commercial Expertise as Manufacturer of Orchard Therapeutics’ Newly Approved Libmeldy™
2 min read
Pierre Fabre Selects AGC Biologics as CDMO to Manufacture the Orphan Drug ER-004
2 min read
AGC Biologics and Horizon Therapeutics plc Expand Partnership
1 min read
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition
2 min read
AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions
2 min read
AGC Biologics Appoints Luca Alberici as the New General Manager/Site Head of the Milan, Italy Site
2 min read
AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab
1 min read
AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage
2 min read
AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program
1 min read
AGC Biologics Expands Development Capacities for pDNA Services at Heidelberg Site
2 min read
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
2 min read
Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine
1 min read
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
2 min read
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
2 min read
AGC Biologics to Participate in First-Ever BIO Digital Conference
2 min read
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment
AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab
2 min read
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine


1 min read
DCAT Week Cancelled, AGC Biologics to Meet Virtually with Industry Leaders
2 min read
AGC Inc. Decides to Launch Voluntary Tender Offer for Shares of Molmed
2 min read
Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases

1 min read
AGC Biologics’ $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint
1 min read
AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations
1 min read
AGC Biologics Appoints New Site Head/General Manager of Bothell, WA Operations

1 min read
U.S. Congresswoman, Suzan DelBene, Visits AGC Biologics Corporate Headquarters

1 min read
Washington State Governor Jay Inslee Visits AGC Biologics Corporate Headquarters
2 min read